Healthcare Equipment and Supplies
Company Overview of Kinetic Concepts, Inc.
Kinetic Concepts, Inc. develops wound healing technologies, medicines, and therapies for caregivers, healthcare professionals, and patients in the United States and internationally. It offers V.A.C., a wound healing modality that delivers negative pressure wound therapy for healing; V.A.C.Ulta, a negative pressure wound therapy system; ABThera, an open abdomen negative pressure therapy; and Prevena, a negative pressure product for the management of closed surgical incisions that continue to drain following sutured or stapled closure. The company also offers Graftjacket, a regenerative tissue matrix for the repair or replacement of damaged or inadequate integumental tissue, such as diabetic f...
12930 Interstate Highway 10 West
San Antonio, TX 78249
Founded in 1976
Key Executives for Kinetic Concepts, Inc.
Chief Executive Officer, President and Director
Interim Chief Financial Officer, Vice President and Corporate Controller
Senior Vice President of Operations
President of Kci Volunteer Council
Group President of Businesses and Innovation
Compensation as of Fiscal Year 2015.
Kinetic Concepts, Inc. Key Developments
Kinetic Concepts, Inc. and KCI USA, Inc. Enter Amendment to Senior Secured Credit Facility
Mar 16 15
Kinetic Concepts, Inc. and KCI USA, Inc. entered into Amendment to Senior Secured Credit Facility. The certain applicable rates were modified so that Dollar Term E-1 Loans bear interest at a rate equal to, at KCI's election, a Eurocurrency rate plus 3.50% or an adjusted base rate plus 2.50%; Euro Term E-1 Loans bear interest at a rate equal to, at KCI's election, a Eurocurrency rate plus 3.75% or an adjusted base rate plus 2.75%, and Term E-2 Loans bear interest at a rate equal to, at KCI's election, a Eurocurrency rate plus 3.00% or an adjusted base rate plus 2.00%. The Eurocurrency rate shall be subject to a floor of 1.00%, and the adjusted base rate shall be subject to a floor of 2.00%. Repayments of Dollar Term E-1 Loans, Euro Term E-1 Loans or Term E-2 Loans within 12 months of the effective date of Amendment in connection with a repricing transaction will be subject to a 1.0% prepayment premium.
Centaur Guernsey L.P. Inc. Announces Executive Changes
Aug 25 14
Centaur Guernsey L.P. Inc. announced that Robert Hureau, Executive Vice President and Chief Financial Officer for Centaur and each of its operating subsidiaries Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Limited, has notified the company that he will be resigning to pursue another career opportunity. Mr. Hureau will continue in his current role until September 23, 2014. Following Mr. Hureau's departure, Brian Busenlehner, Vice President, Corporate Controller, will serve as interim Chief Financial Officer, working closely with President and CEO Joe Woody and the company's senior leadership team on all financial matters. Mr. Busenlehner has served as Vice President, Controller since 2007 and in that role has been responsible for global accounting, financial consolidation and external reporting in addition to providing leadership in support of the company's Global Shared Service Center in Budapest, Hungary.
Kinetic Concepts, Inc. Announces Settlement and Release Agreement with Wake Forest University Health Sciences
Jul 1 14
Kinetic Concepts, Inc. entered into a settlement and release agreement with Wake Forest University Health Sciences to fully and finally resolve the pending patent disputes between them regarding Wake Forest's negative pressure wound therapy (NPWT) patents formerly licensed to KCI. The Settlement Agreement resolves all disputes between KCI and Wake Forest, and their respective affiliates, related to Wake Forest's NPWT patents that were the subject of a 1993 license agreement between KCI and Wake Forest. To fully resolve all the pending disputes between KCI and Wake Forest, KCI agreed to pay Wake Forest retrospective U.S. patent royalties in the amount of $280 million, according to the following schedule: $80 million to be paid in July, 2014, $85 million to be paid in June 2015, $85 million to be paid in June 2016, and $30 million to be paid in June, 2017. The Settlement Agreement includes a stipulated dismissal with prejudice of the lawsuits between KCI and Wake Forest, including the lawsuit that was previously scheduled to begin trial on July 28, 2014 in the U.S. District Court for the Western District of Texas, San Antonio Division.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|